The nine-valent cervical cancer vaccine can be administered at ages 9-45.
Nine-valent cervical cancer vaccine can prevent 9 types of human papillomavirus infections, can effectively prevent warts and more than 90% of cervical cancer, recommended to be vaccinated with one dose in 0, 2, and 6 months, and usually complete the 3 injections within 6 months, and complete the vaccination within one year at the latest.
The age range for the nine-valent cervical cancer vaccination is 9-45 years old. It should be noted that people who have hypersensitivity to the active ingredient of the vaccine or any of the excipient components are prohibited from receiving the HPV vaccine, and those who have symptoms of hypersensitivity after injection of the product should not be revaccinated with the product. Regular cervical cancer screening is still required after HPV vaccination.